These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 26328490

  • 1. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P, Tiwari RV, Sylvester PW.
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [Abstract] [Full Text] [Related]

  • 2. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P, Tiwari RV, Sylvester PW.
    Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
    [Abstract] [Full Text] [Related]

  • 3. γ-Tocotrienol Suppression of the Warburg Effect Is Mediated by AMPK Activation in Human Breast Cancer Cells.
    Dronamraju V, Ibrahim BA, Briski KP, Sylvester PW.
    Nutr Cancer; 2019 Aug; 71(7):1214-1228. PubMed ID: 30955359
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH.
    PLoS One; 2015 Aug; 10(7):e0132285. PubMed ID: 26158266
    [Abstract] [Full Text] [Related]

  • 5. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ, Sylvester PW.
    Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
    [Abstract] [Full Text] [Related]

  • 6. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR, Ayoub NM, Abuasal BS, Kaddoumi A, Sylvester PW.
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR, Ayoub NM, Sylvester PW.
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [Abstract] [Full Text] [Related]

  • 8. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
    Tiwari RV, Parajuli P, Sylvester PW.
    Exp Biol Med (Maywood); 2014 Jan; 239(1):33-44. PubMed ID: 24231340
    [Abstract] [Full Text] [Related]

  • 9. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV, Sylvester PW.
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [Abstract] [Full Text] [Related]

  • 10. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
    Zhang X, Ai Z, Chen J, Yi J, Liu Z, Zhao H, Wei H.
    Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
    [Abstract] [Full Text] [Related]

  • 11. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB, Sylvester PW.
    Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
    [Abstract] [Full Text] [Related]

  • 12. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
    Sylvester PW, Shah SJ, Samant GV.
    J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
    [Abstract] [Full Text] [Related]

  • 13. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV, Parajuli P, Sylvester PW.
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [Abstract] [Full Text] [Related]

  • 14. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X, Liu Y, Zhao Y, Sun X, Fan D, Guo L.
    PLoS One; 2017 Oct; 12(9):e0184213. PubMed ID: 28886081
    [Abstract] [Full Text] [Related]

  • 15. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB, Bachawal SV, Sylvester PW.
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [Abstract] [Full Text] [Related]

  • 16. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG, Dronamraju V, Sylvester PW.
    Biol Pharm Bull; 2016 Jun; 39(12):1974-1982. PubMed ID: 27904039
    [Abstract] [Full Text] [Related]

  • 17. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
    Sylvester PW, Ayoub NM.
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
    [Abstract] [Full Text] [Related]

  • 18. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
    Wali VB, Bachawal SV, Sylvester PW.
    Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
    [Abstract] [Full Text] [Related]

  • 19. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H, Takita M, Saruwatari K, Umemura S, Obata Y, Ishii G, Matsumoto S, Sugiyama E, Ochiai A, Abe R, Goto K, Esumi H, Tsuchihara K.
    J Biol Chem; 2015 Jul 10; 290(28):17495-504. PubMed ID: 26023239
    [Abstract] [Full Text] [Related]

  • 20. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV, Wali VB, Sylvester PW.
    BMC Cancer; 2010 Mar 08; 10():84. PubMed ID: 20211018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.